Exit events / 843
#843
| id | 843 |
|---|---|
| company_id | 10634 |
| event_type | acquisition |
| event_date | — |
| counterparty_company_id | 17214 |
| successor_company_id | — |
| deal_value_usd | 1500000000.0 |
| deal_value_basis | reported |
| notes | Announced acquisition ([subscription] Repligen acquired BioLife, a Bothell-based cell and gene therapy tools maker, for $1.5B ($11.25 cas... |
| source_urls | ["https://link.mail.beehiiv.com/v1/c/ya4vQ%2BJ06p8qjyGqB4MoauAmHagOG6HV3TAOvHiL9X16NivBCByg6KzC41JS%0AoW%2FpLfgEiZaZSmJjfDStrqm9H3ocY8KoJ... |
| payload | {"signal_id"=>3440, "deal_status"=>"announced", "subject_role"=>"target", "counterparty_name"=>"Repligen"} |
| entered_by_person_id | — |
| entered_at | 2026-10-04T16:10:02.276567+00:00 |
| data_source | email_signal:19f942616f2e0a8f |
| data_confidence | reported |